Industry

LITTLE RIVER, S.C.–(BUSINESS WIRE)–$PCTL #healthcare–PCT LTD (OTC Pink: PCTL): Since the initial outbreak of the COVID-19 virus in early 2020, healthcare systems around the world have faced numerous additional widespread infection threats. Whether these are new waves of COVID variants or the recent spread of monkeypox, they illustrate the need for hospitals and long-term care … [Read more…]

WILMINGTON, Del.–(BUSINESS WIRE)–Dermaliq Therapeutics, Inc. (Dermaliq), a private, clinical stage pharmaceutical company with a focus on dermatology, today announced first patient dosed in a Phase 1b/2a trial with DLQ02, a topical calcineurin inhibitor. The trial is designed to evaluate the safety, systemic absorption, pharmacodynamics, and clinical efficacy of DLQ02 in patients with plaque psoriasis. “DLQ02 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bed Monitoring Systems and Baby Monitoring Systems – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Bed Monitoring Systems and Baby Monitoring Systems Market to Reach US$1.8 Billion by the Year 2026 Growth in the global market is mainly attributed to rising aging population, increasing uptake of unobtrusive … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Metabolic Partnering 2015-2022: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Metabolic Partnering 2015 to 2022 provides the full collection of 1100+ Metabolic disease deals signed between the world’s pharmaceutical and biotechnology companies since 2015. Most of the deals included within the report occur when a licensee … [Read more…]

ELMSFORD, N.Y.–(BUSINESS WIRE)–NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update in a letter to shareholders from its Chief Executive Officer, Brian Murphy: To Our Shareholders: We are making progress toward further commercialization and efficiencies of our … [Read more…]

OMAHA, Neb.–(BUSINESS WIRE)–#Maternalhealth–Medica has provided $500,000 in funding to support Nebraska organizations throughout the state that address social issues that impact the health of people with low incomes. The funding is in addition to the approximately $2 million in support provided by Medica for Nebraska nonprofit health organizations since 2018. The funding falls into six … [Read more…]

Three machine deal expands potential of biology-guided radiotherapy to Pacific Northwest HAYWARD, Calif.–(BUSINESS WIRE)–#BgRT—RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT), a new modality that uses emissions generated from the cancer itself to direct radiotherapy, today announced a three-system contract with Select Healthcare, a developer of affiliated cancer facilities throughout the United States. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Laparoscopy and Endoscopy Devices Market – A Global and Regional Analysis: Focus on Therapeutic Area, End User, Product Type, and Country-Wise Analysis – Analysis and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering. The global laparoscopy and endoscopy devices market was valued at $23,809.2 million in 2021 and is projected to reach … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Colorectal Cancer Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Modality and End-user” report has been added to ResearchAndMarkets.com’s offering. The global colorectal cancer market is expected to grow from US$ 18,619.3 million in 2022 to US$ 24,078.5 million by 2028. Factors such as the increasing prevalence of colorectal cancer, … [Read more…]

Widely available drug reduced emergency room visits, hospitalization, and death by COVID-19 by more than half if started within 4 days of symptoms SAN FRANCISCO–(BUSINESS WIRE)–The widely available diabetes drug metformin reduced serious outcomes by more than half if started within 4 days of COVID symptoms in a large, double-blind randomized controlled trial, the University … [Read more…]